- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
-
Your selected country is
United States
- Change country/language
-
Promotions
-
sk-testpage
-
BD Primer Program
-
BD Discovery 2021
-
Reagents
-
DO NOT PUBLISH
-
Reagentes Com Valor Promocional
-
Lunch Box Giveaway
-
EQCプログラム 外部精度管理 施設間精度管理
-
Backbone Reagents Promo
-
Backbone Reagents Promo
-
Classic Dyes
-
Back to Lab
-
End of Year
-
Tcell Backbone Panel Promotion
-
BD Horizon™ Human T Cell Backbone Panel
-
New Lab Promotion
-
Flash Sale
-
BD Panel Design Program
-
Real Dyes Sample Offer
-
BD’s 50 Years of Innovation Research Instrument Promotion
-
BD FACSLyric™ Flow Cytometers 50th Anniversary Promo
-
BD FACSAria™ Customer Loyalty Promotion
-
FlowJo™ Software Promotion
-
BD® Research Cloud Promotion
-
sk-testpage
-
Custom BD® AbSeq
-
Custom AbSeq FAQ Answer 2
-
Custom AbSeq FAQ Answer 3
-
Custom AbSeq FAQ Answer 4
-
Custom AbSeq FAQ Answer 5
-
Custom AbSeq FAQ Answer 6
-
Custom AbSeq FAQ Answer 7
-
Custom AbSeq FAQ Answer 8
-
Custom AbSeq FAQ Answer 9
-
Custom AbSeq FAQ Answer 10
-
Custom AbSeq FAQ Answer 11
-
Custom AbSeq FAQ Answer 12
-
Custom AbSeq FAQ Answer 13
-
Custom AbSeq FAQ Answer 14
-
Custom AbSeq FAQ Answer 15
-
Custom AbSeq FAQ Answer 16
-
Custom AbSeq FAQ Answer 17
-
Custom AbSeq FAQ Answer 18
-
Custom AbSeq FAQ Answer 19
-
Custom AbSeq FAQ Answer 20
-
Custom AbSeq FAQ Answer 2
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- Change country/language
Old Browser
Your account has been put on hold due to inactivity. To re-activate, check your account information and make all necessary updates.
Looks like you're visiting us from {{countryName}}.
Would you like to remain on the current country site or be redirected to one based on your location?
live copy GB
Your account has been put on hold due to inactivity. To re-activate, check your account information and make all necessary updates.
NSCLC scRNA-seq Atlas Shows Variety and Versatility of Neutrophils in Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer (NSCLC) contains a diversity of histological subtypes and specific mutational signatures. Single-cell RNA sequencing (scRNA-seq) technologies have enabled the characterisation of the NSCLC Tumour Microenvironment (TME).
However, there is a lack of understanding on how different immune cell phenotypes may contribute to therapy resistance. There is a paucity of data on neutrophils, which may mediate pro- and anti-tumour inflammatory pathways.
Atlas Maps Cells from Patients with Non-Small Cell Lung Cancer1
Salcher et al. built a comprehensive, large-scale NSCLC scRNA-seq atlas out of 29 datasets from 19 studies with 556 samples containing 1,283,972 cells. This atlas includes a total of 318 individuals (232 patients with NSCLC and 86 non-cancer controls).
Using the atlas, they stratified patients with NSCLC based on the infiltration patterns of their TMEs. By analysing the genomic and clinical information of bulk samples, they stratified the patients into four separate tumour immune phenotypes.
Tumour Immune Phenotypes1
- Immune-deserted tumours
- B-cell tumours
- Myeloid tumours
- T-cell tumours
For each of the four immune phenotypes, they then identified tumour-cell-based TME imprinting characteristics.
Focus on Neutrophils1
To make up for the lack of neutrophil single-cell data, they included samples from 17 patients with NSCLC. They carried out an in-depth characterisation of tissue-resident neutrophils (TRNs), including tumor-associated neutrophils (TANs) and normal adjacent tissue-associated neutrophils (NANs), using the BD Rhapsody™ Single-Cell Analysis System.
One of the TAN subsets appears to present antigen-like properties at the tumour site. This may generate anti-tumour immunity. They also found evidence linking TRNs to therapy failure using a gene signature specific to TANs.
This large-scale atlas provides us with a better understanding of the characteristics of TRN subsets in NSCLC.
Read the full study: High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer
References
- Salcher S, Sturm G, Horvath L, et al. High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer. Cancer Cell. 2022;40(12):1503-1520.e8. doi:10.1016/j.ccell.2022.10.008
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
© 2023 BD. All rights reserved. Unless otherwise noted, BD, the BD Logo and all other trademarks are the property of Becton, Dickinson and Company or its affiliates.
Report a Site Issue
This form is intended to help us improve our website experience. For other support, please visit our Contact Us page.